Full Text
EE505 Canada's Evolving Market for Biosimilars and What It Means for Payers

Abstract

Authors

Y Zhang B Wladyka

Back to Volume 25, Supplemental Issue 7S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×